FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreMain Content
Lead the Future of Alzheimer's Imaging — Join ALZ-NET
Oct. 2, 2025
The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) Imaging Network, managed by the ACR Center for Research and Innovation, offers participating imaging facilities exclusive access to discounted FDA-cleared AI tools and data visualization resources— to enhance Alzheimer’s imaging workflows and patient safety.
With 41 imaging facilities already participating, another 72 in start-up, and 3,184 patients enrolled from 115 referring dementia practices nationwide, ALZ-NET supports real-world evidence generation to inform FDA safety assessments and clinical guidelines – including appropriate PET use and MR safety.
Imaging facilities are invited to contribute longitudinal brain imaging data from patients receiving FDA-approved Alzheimer’s treatments.
